Human factors (HF) validation testing is the evaluation that confirms that the intended users of a medical device can safely and effectively operate it under realistic use conditions. FDA Guidance (Applying Human Factors and Usability Engineering to Medical Devices guidance, issued August 3, 2026) emphasizes this evaluation as a required step in verifying that use-related risks have been adequately addressed before commercialization.
Unfortunately, device readiness gaps can often threaten HF validation outcomes. Those gaps – which indicate a device or its supporting evidence is not actually ready for final testing – could be related to an incomplete definition of the intended users and use environments, noncomprehensive risk documentation, lack of prior formative evaluations, inadequate residual risk analysis, or immaturity of the user interface design. Therefore, from a Human Factors perspective, how can a manufacturer determine whether a device is ready for this evaluation?
In this blog, Maria Mawhinney, Human Factors Engineer, and Kate Cox, Director of Human Factors, will go over some common gaps Ensera Design has observed when we are contracted to conduct HF validation studies. As the user-centered design and human factors engineering processes are long and complex, this list is non-exhaustive.
